CD24 and obesity due to melanocortin 4 receptor deficiency: Silencing of the CD24-Siglec-E pathway could deteriorate the diet-induced metabolic disorders, including obesity, dyslipidemia, insulin resistance, and nonalcoholic steatohepatitis (NASH), which could be alleviated by CD24Fc treatment (14).